Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cheng-Qiong Mao
Synthetic Lethal Therapy for KRAS Mutant Non-Small-Cell Lung Carcinoma With Nanoparticle-Mediated CDK4 siRNA Delivery
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
Nanoparticle Delivery of Pooled siRNA for Effective Treatment of Non-Small Cell Lung Caner
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Atorvastatin Overcomes Gefitinib Resistance in KRAS Mutant Human Non-Small Cell Lung Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
PLoS ONE
Multidisciplinary
KRAS Mutation, KRAS–LCS6 Polymorphism, and Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Recent Developments in Nanoparticle-Based siRNA Delivery for Cancer Therapy
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
P2.03-14 PKCi-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant and Squamous Cell Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Antibody-Mediated Delivery of Anti-Kras-siRNA in Vivo Overcomes Therapy Resistance in Colon Cancer
Clinical Cancer Research
Cancer Research
Oncology
Mutational Profiling of KRAS and Its Association With Non-Small Cell Lung Carcinoma in Indian Kashmiri Population
Canadian Journal of Biotechnology
